SMG · Scotts Miracle-Gro Co
Price & Indicators
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders SellIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | $686.6M | Nine Months Ended | — |
| Net leverage ratio | 3.78 | third quarter | — |
| Non-GAAP adjusted gross margin rate non-GAAP | 31.3% | third quarter | — |
| Net leverage | 3.71 | Q2 FY2026 | — |
|
|
|||
| Non-GAAP adjusted EBITDA non-GAAP | $437.4M | Q2 FY2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Agricultural Inputs — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SMG
this stock
Scotts Miracle-Gro Co
|
$3.62B | +4.4% | +6.2% | 51.8 | 8.4% |
|
CTVA
Corteva, Inc.
|
$51.16B | +14.4% | +2.9% | 50.1 | 2.7% |
|
NTR
Nutrien Ltd.
|
$32.06B | +10.6% | — | — | 0.8% |
|
CF
CF Industries Holdings, Inc.
|
$17.90B | +53.0% | +19.3% | 8.8 | 5.3% |
|
YARIY
Yara International ASA
|
$11.21B | +8.8% | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SMG | -3.1% | -14.1% | -11.8% | -7.2% | +4.4% |
| SPY | +0.4% | +4.5% | +13.8% | +3.9% | +13.9% |
| vs SPY | -3.5% | -18.6% | -25.6% | -11.1% | -9.4% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.